“…We further recommended antibiotic treatment for those seropositive patients with unexplained CSF pleocytosis, elevated CSF Lyme antibody index, or rising serum levels of Borrelia-specific antibodies. 1 Earlier laboratory kits to screen for Lyme disease, including ours, lacked specificity, contributing to overdiagnosis. 3 Since that report, 1 our laboratory instituted two changes: (1) we started using a colorimetric enzyme immunoassay (General Biometrics, San Diego, CA) with greater specificity than earlier assays for laboratory screening of Lyme disease but still highly sensitive; (2) we followed the recommendations of the Centers for Disease Control and Prevention (CDC), which specify that serologic testing for Lyme disease be performed using a two-step process.…”